Garbriel Afram
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 06, 2022
Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.Gabriel Afram, Roza Chaireti, Katarina Uttervall
|Jan 20, 2021
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.Gabriel Afram, Katharina Helene Susek, Katarina Uttervall
|Apr 14, 2020
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment.Garbriel Afram, Charlotte Gran, Johanna Borg Bruchfeld
|Apr 27, 2018
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.Gabriel Afram, Jose Antonio Pérez Simón, Mats Remberger
Pageof 1
Frequent Collaborators
2 joint publications
Arnika Kathleen Wagner
2 joint publications
Roza Chaireti
1 joint publications
Katharina Helene Susek
1 joint publications
Katarina Uttervall
1 joint publications
Vincent Luong
1 joint publications
Johan Lund
1 joint publications
Muhammad Kashif
1 joint publications
Gösta Gahrton
1 joint publications
Evren Alici
1 joint publications
Hareth Nahi
